One important metric to look for in a stock is an 80 or higher Relative Strength Rating. ICU Medical just hit that mark, with a jump from 76 to 85 Monday.
This proprietary rating identifies market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History shows that the market's biggest winners often have an 80 or better RS Rating in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock is able to form a consolidation and break out.
Top and bottom line growth moved higher in the company's most recent quarter. Earnings were up 34%, compared to 1% in the prior report. Revenue increased from 6% to 7%. The next quarterly numbers are expected on or around May 12.
The company holds the No. 21 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Axogen are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
